Filter Results :

Your search for Biotech and Diagnostics returned 11 reports

Sort by


Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare comp...

$ 2,995.00

Read More

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies "The Global Royalty Fi...

$ 1,995.00

Read More

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies "The Global Co-development ...

$ 2,995.00

Read More

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, t...

$ 2,995.00

Read More

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies ...

$ 2,995.00

Read More

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies "The Global Joint Venture Part...

$ 1,995.00

Read More

Stable Isotope Labeled Compounds Market by Type (C13, D, 018, N15 label), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital) - Global Forecast to 2022

26 Jul 2017  |  Published by:  MarketsandMarkets
The stable isotope-labeled compounds market is projected to grow at a CAGR of 2.94%.The global stable isotope-labeled compounds market is estimated to grow at a CAGR of 2.94% from 2017 to 2022, to reach USD 294.2 million by 2022. Increase in research activities in the pharmaceutical and biotechnolog...

$ 5,650.00
$ 4,520.00
( Save 20% )

Read More

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies The Global Option and Evalu...

$ 2,995.00

Read More

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals "The Global Asset Purchase Deals in Pharma, Biotech and Diagnostic...

$ 2,995.00

Read More

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies "The Global Manufa...

$ 2,995.00

Read More

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies The Global Distribution ...

$ 2,995.00

Read More
Total 11 records.